Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...

After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to ...

A new HPV vaccine induced regression of precancerous cervical lesions in 50% of patients and led to viral clearance in some ...

In the latest study, researchers found the main genetic mutations in renal cell cancer, possibly by using artificial intelligence (AI). The scientists injected mRNA vaccine made against proteins ...

Neoantigen-targeting personalized cancer vaccines (PCVs) are highly immunogenic in high-risk clear cell renal cell carcinoma (RCC) and can target key driver mutations and induce antitumor immunity, ...

Vaccines generated using the cells left over after tumour removal surgery could help to keep patients from redeveloping ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We get into more ...

DES MOINES — State funding for the Double up Food Bucks Program, which provides a one-to-one match to Supplemental Nutrition ...

During health secretary nominee Robert F. Kennedy Jr.'s Jan. 29 Senate confirmation hearing, Sen. Elizabeth Warren, D-Mass., ...

The stop-work order on U.S.A.I.D.-funded research has left thousands of people with experimental drugs and devices in their ...